<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CILOSTAZOL</span><br/>(sil-os'tah-zol)<br/><span class="topboxtradename">Pletal<br/></span><b>Classifications:</b> <span class="classification">cardiovascular agent</span>; <span class="classification">coagulator</span>; <span class="classification">vasodilator</span>; <span class="classification">antiplatelet agent</span>; <span class="classification">phosphodiesterase inhibitor</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>50 mg, 100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Inhibition of an isoenzyme which results in vasodilatation and inhibition of platelet aggregation induced by collagen or arachidonic
         acid.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Increases the skin temperature of the extremities and improves claudication. Effectiveness is indicated by increased ability
         to walk further without claudication.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Intermittent claudication.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Congestive heart failure of any severity; hypersensitivity to cilostazol; pregnancy (category C), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Intermittent Claudication</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 100 mg b.i.d. 0.5 h before or 2 h after meals, may need to reduce to 50 mg b.i.d. with concomitant ketoconazole, itraconazole,
               erythromycin, diltiazem or omeprazole<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give at least ½ h before or 2 h after a meal. Do not give with grapefruit juice.</li>
<li>Store at 20°25° C (68°77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Back pain, <span class="speceff-common">headache,</span> infection, myalgia. <span class="typehead">CNS:</span> Dizziness, vertigo. <span class="typehead">CV:</span> Palpitations, tachycardia. <span class="typehead">GI:</span> Abdominal pain, <span class="speceff-common">abnormal stools, diarrhea,</span> dyspepsia, flatulence, nausea. <span class="typehead">Respiratory:</span> Cough, pharyngitis, rhinitis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Diltiazem,</b>
<b>erythromycin,</b>
<b>fluconazole,</b>
<b>fluvoxamine,</b>
<b>fluoxetine,</b>
<b>ketoconazole,</b>
<b>itraconazole,</b>
<span class="classification">macrolide antibiotics</span>, <b>miconazole,</b>
<b>nefazodone,</b>
<b>omeprazole,</b>
<b>sertraline</b> may increase <b>cilostazol</b> levels. <span class="typehead">Food:</span> Grapefruit juice may decrease absorption. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Well absorbed from GI tract. <span class="typehead">Onset:</span> 24 wks. <span class="typehead">Distribution:</span> 9598% protein bound. Smoking may decrease serum levels. May be excreted in breast milk. <span class="typehead">Metabolism:</span> Metabolized by CYP3A4 to active metabolites. <span class="typehead">Elimination:</span> Metabolites primarily excreted in urine. <span class="typehead">Half-Life:</span> 113 hr. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor therapeutic effectiveness indicated by ability to walk farther without leg pain.</li>
<li>Monitor for S&amp;S of CHF. Do not give cilostazol to patients with preexisting CHF.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid grapefruit or grapefruit juice while taking cilostazol.</li>
<li>Allow 212 wk for therapeutic response.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>